chevron_leftBack
As of 6 June 2026, Sirio Pharma Co., Ltd. has a market cap of $884.39M USD, ranking #11442 globally and #3309 in China.
It ranks #1038 in the Healthcare sector, and #57 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$884.39MUSD
5.99B CNY
Enterprise Value
$1.05BUSD
7.14B CNY
Revenue (TTM)
$657.92MUSD
4.45B CNY
EBITDA (TTM)
$86.77MUSD
587.76M CNY
Net Income (TTM)
$51.04MUSD
345.53M CNY
EBITDA Margin
13%
Profit Margin
7.8%
PE Ratio
17.2
Forward PE
15.7
PS Ratio
1.3
PB Ratio
2.2
EV/EBITDA
11.5
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Peiqing Li
open_in_new
Employees
2,776
Founded
1993
Website
siriopharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.4% | -4.3% | -5.9% | -18% | -19% | 0.7% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300791
仙乐健康科技股份有限公司 Class A
ISIN: CNE100003NB0
Shares Out.:
Shares Outstanding:
308.692M1
Shares Float:
104.104M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
19.50 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sirio Pharma Co., Ltd.
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.86B
2K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.1B
929%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.22B
490%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.21B
376%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.27B
270%
22.12B CNY
|
8.1
|
|
|
$2.74B
210%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
4K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
3K%
|
-
|
|
NSE: CIPLA
|
$11.12B
1K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
1K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.79B
894%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.43B
853%
807.02B INR
|
23.1
|
chevron_leftBack